Clinical trial
A Randomized Clinical Trial for the Treatment of Refractory Status Epilepticus
NCT00265616 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Clinical Trial for the Treatment of Refractory Status Epilepticus
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- May 31, 2006
- Completion date
- March 31, 2010
- Enrollment
- 23 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.